EP1012260A4 - INTERLEUKINE-20 - Google Patents

INTERLEUKINE-20

Info

Publication number
EP1012260A4
EP1012260A4 EP98936854A EP98936854A EP1012260A4 EP 1012260 A4 EP1012260 A4 EP 1012260A4 EP 98936854 A EP98936854 A EP 98936854A EP 98936854 A EP98936854 A EP 98936854A EP 1012260 A4 EP1012260 A4 EP 1012260A4
Authority
EP
European Patent Office
Prior art keywords
interleukine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98936854A
Other languages
German (de)
French (fr)
Other versions
EP1012260A1 (en
Inventor
Steven M Ruben
Reinhard Ebner
Roxanne D Duan
Kimberly A Florence
Jing-Shan Hu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1012260A1 publication Critical patent/EP1012260A1/en
Publication of EP1012260A4 publication Critical patent/EP1012260A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP98936854A 1997-07-16 1998-07-15 INTERLEUKINE-20 Withdrawn EP1012260A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5287097P 1997-07-16 1997-07-16
US52870P 1997-07-16
US6014097P 1997-09-26 1997-09-26
US60140P 1997-09-26
PCT/US1998/014609 WO1999003982A1 (en) 1997-07-16 1998-07-15 Interleukin-20

Publications (2)

Publication Number Publication Date
EP1012260A1 EP1012260A1 (en) 2000-06-28
EP1012260A4 true EP1012260A4 (en) 2001-05-09

Family

ID=26731192

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98936854A Withdrawn EP1012260A4 (en) 1997-07-16 1998-07-15 INTERLEUKINE-20

Country Status (5)

Country Link
EP (1) EP1012260A4 (en)
JP (1) JP2001510035A (en)
AU (1) AU8571198A (en)
CA (1) CA2296762A1 (en)
WO (1) WO1999003982A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579520B2 (en) 1998-05-15 2003-06-17 Genentech, Inc. IL-17 related mammalian cytokine polypeptides (IL-17E)
US6569645B2 (en) 1999-05-14 2003-05-27 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US6486301B1 (en) * 1997-07-16 2002-11-26 Human Genome Sciences, Inc. Interleukin-20
US6562578B1 (en) 1999-01-11 2003-05-13 Schering Corporation IL-17-like cytokine binding compounds and antibodies
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
EP3112468A1 (en) * 1998-05-15 2017-01-04 Genentech, Inc. Il-17 homologous polypeptides and therapeutic uses thereof
EP1865061A3 (en) * 1998-05-15 2007-12-19 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
AU740405B2 (en) * 1998-05-15 2001-11-01 Genentech Inc. IL-17 homologous polypeptides and therapeutic uses thereof
JP2003521239A (en) * 1999-04-09 2003-07-15 キュラジェン コーポレイション Novel human proteins and polynucleotides encoding them
DE60045139D1 (en) 1999-12-23 2010-12-02 Zymogenetics Inc Soluble interleukin-20 receptor
US6610286B2 (en) 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
US20040043397A1 (en) 2000-01-11 2004-03-04 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
JP2016047051A (en) * 1999-12-23 2016-04-07 ジェネンテック， インコーポレイテッド IL-17 homologous polypeptide and therapeutic uses thereof
US7122632B2 (en) 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
EP2295079A3 (en) * 1999-12-23 2011-03-23 ZymoGenetics, L.L.C. Method for treating inflammation
CA2391374A1 (en) * 1999-12-23 2001-06-28 Genentech, Inc. Il-17 homologous polypeptides and therapeutic uses thereof
EP1259253A2 (en) * 2000-02-29 2002-11-27 ZymoGenetics, Inc. Methods for promoting production of myelin by schwann cells
US7718397B2 (en) 2000-03-21 2010-05-18 Genentech, Inc. Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP2177616B1 (en) 2000-08-08 2012-02-29 ZymoGenetics, Inc. Soluble zcytor 11 cytokine receptors
EP1803733B1 (en) 2000-09-15 2010-03-10 ZymoGenetics, Inc. Polypeptides comprising the extracellular domains of IL-20RA and/or IL-20RB
IL161978A0 (en) * 2001-12-17 2005-11-20 Zymogenetics Inc Method for treating cervical cancer
EP1498137A1 (en) * 2002-04-25 2005-01-19 Chugai Seiyaku Kabushiki Kaisha Remedy for lung cancer
EP1606317B1 (en) 2003-03-24 2010-07-28 ZymoGenetics, Inc. Anti-il-22ra antibodies and binding partners and methods of using in inflammation
EP2143733A1 (en) 2003-11-21 2010-01-13 ZymoGenetics, Inc. ANTI-IL-20 antibodies and binding partners and methods of using in inflammation
EA015706B1 (en) 2004-10-22 2011-10-31 Займоджинетикс, Инк. Monoclonal antibody or its fragment, binding to il-22ra polypeptide, humanized antibody derived from said antibody, hybridomas and use of said antibody
US20070053872A1 (en) * 2005-08-04 2007-03-08 Moore Emma E Treatment of wounds using il-17b
JP2010509364A (en) * 2006-11-08 2010-03-25 ザイモジェネティクス， インコーポレイテッド IL-17B for use in wound healing
CA2721713C (en) 2008-05-05 2019-07-09 Novimmune Sa Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
EP2427203B1 (en) 2009-05-05 2018-10-17 Novimmune S.A. Anti-il-17f antibodies and use thereof
US8454956B2 (en) 2009-08-31 2013-06-04 National Cheng Kung University Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodies
EP3409289B1 (en) 2010-02-26 2020-09-30 Novo Nordisk A/S Stable antibody containing compositions
RU2012153786A (en) 2010-05-28 2014-07-10 Ново Нордиск А/С STABLE MULTI-DOSE COMPOSITIONS CONTAINING ANTIBODY AND CONSERVANT
US9221904B2 (en) 2012-07-19 2015-12-29 National Cheng Kung University Treatment of osteoarthritis using IL-20 antagonists
US8603470B1 (en) 2012-08-07 2013-12-10 National Cheng Kung University Use of IL-20 antagonists for treating liver diseases
US8852588B2 (en) 2012-08-07 2014-10-07 National Cheng Kung University Treating allergic airway disorders using anti-IL-20 receptor antibodies

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049310A1 (en) * 1997-04-25 1998-11-05 Zymogenetics, Inc. Mammalian cytokine-like factor 7

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562333B1 (en) * 1993-06-14 2003-05-13 Schering Corporation Purified mammalian CTLA-8 antigens and related reagents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049310A1 (en) * 1997-04-25 1998-11-05 Zymogenetics, Inc. Mammalian cytokine-like factor 7

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL EMBL; 16 September 1996 (1996-09-16), WUECHNER: "H. sapiens FGFR3 gene, intron 7", XP002161117 *
LI ET AL.: "Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family", PROC. NATL. ACAD. SCI. USA, vol. 97, no. 2, 18 January 2000 (2000-01-18), pages 773 - 778, XP002161115 *
See also references of WO9903982A1 *
SHI ET AL.: "A novel cytokine receptor-ligand pair: Identification, molecular characterization and in vivo immunomodulatory activty", J. BIOL. CHEM., vol. 275, no. 23, 23 June 2000 (2000-06-23), pages 19167 - 19176, XP002161114 *
YAO ET AL.: "Human IL-17: a novel cytokine derived from T cells", J. IMMUNOL., vol. 155, no. 12, 15 December 2000 (2000-12-15), pages 5483 - 5486, XP000602481 *

Also Published As

Publication number Publication date
AU8571198A (en) 1999-02-10
JP2001510035A (en) 2001-07-31
EP1012260A1 (en) 2000-06-28
CA2296762A1 (en) 1999-01-28
WO1999003982A1 (en) 1999-01-28

Similar Documents

Publication Publication Date Title
DE19810476B4 (en) Laryngomaske
DE59806832D1 (en) ZEMENTATIONSHILFSMITTEL
ATA93198A (en) FLUOXETINPELLETS
DE69825349D1 (en) Motoransteuerbaugruppe
FI972025A0 (en) Vaeggkonstruktion
DE59803185D1 (en) Baulaser
DE59806720D1 (en) EINSPRITZVENTIL
DE59804631D1 (en) Diketopyrrolopyrrolzusammensetzungen
DE59802506D1 (en) Weichspülmittelzusammemsetzung
DE59804377D1 (en) Kryoventil
DE59806387D1 (en) Azofarbstoffmischungen
DE59710388D1 (en) micropolarimeter
DE59801498D1 (en) Dioxacycloalkan-8-one
DE59805979D1 (en) Organo-Oligomers
ATE236897T1 (en) 3-BENZYLPIPERIDINE
ATA112597A (en) SNOWBOARD - BINDING
DE59806790D1 (en) Acrylesterkautschukpartikel
DE59806501D1 (en) tailcutter
DE59806025D1 (en) Normalsäschar
DE59805424D1 (en) TRANSVERSALMODENRESONATORFILTER
DE59805053D1 (en) Bogenflexodruckmaschine
ATA46498A (en) KUNSTSTOFFGLEITBAHN
ATA86797A (en) VERSCHLEISSSCHUH
DE59805451D1 (en) COILBOXOFEN
DE59800820D1 (en) STILLESS KNEE-KNEE OPROTHESIS

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000216

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): FR

A4 Supplementary search report drawn up and despatched

Effective date: 20010323

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): FR

17Q First examination report despatched

Effective date: 20030918

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050127